We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 22, 2022

Risk of Myocarditis and Pericarditis After COVID-19 mRNA Vaccination in the US

The Lancet


Additional Info

The Lancet
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
Lancet 2022 Jun 11;399(10342)2191-2199, HL Wong, M Hu, CK Zhou, PC Lloyd, KL Amend, DC Beachler, A Secora, CN McMahill-Walraven, Y Lu, Y Wu, RP Ogilvie, C Reich, DA Djibo, Z Wan, JD Seeger, S Akhtar, Y Jiao, Y Chillarige, R Do, J Hornberger, J Obidi, R Forshee, A Shoaibi, SA Anderson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading